Health Economics

With clients in all corners of healthcare and the pharmaceutical sectors, we understand the complexities of different health economies better than any of our rivals. Whether through the CHKS health economics unit, formerly Cardiff Research Consortium (CRC), or working with our FESC partners (as Partners in Commissioning), we provide a comprehensive range of health economics solutions from budget impact modelling and cost effectiveness appraisal to joint strategic needs assessment.

Our broad experience in the pharmaceutical sector, commissioning and healthcare provision gives us an unrivalled understanding of epidemiology and disease modelling – a crucial added perspective when managing health economies, evaluating effective commissioning and provision.

For the pharmaceutical sector

The responsibility for pharmaceutical companies to maximise revenue by improving the market access of the portfolio is a global challenge.  Success involves turning regulatory compliance into a business advantage with robust and commercially relevant evidence.  It is no longer enough to provide the safety and efficacy data for regulatory purposes; increasingly there is a requirement to provide value for money arguments in the form of cost effectiveness data and evidence based prescribing.

We provide critical, evidence based, real world data that enables healthcare strategists within the pharmaceutical sector to define and model healthcare strategy.